← Back to headlines
Immunovant Stock Rises 30% Despite Investor Trimming Stake
Immunovant stock surged by 30% even after an investor reduced their stake by $3 million, with analysts still maintaining a bullish outlook on the company.
11 Mar, 17:08 — 11 Mar, 17:08
Sources
Showing 1 of 1 sources
